These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2165009)

  • 21. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease.
    Palmer AM; Procter AW; Stratmann GC; Bowen DM
    Neurosci Lett; 1986 May; 66(2):199-204. PubMed ID: 3014387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulation of cortical cholinergic deficits--a novel experimental approach to study pathogenetic aspects of Alzheimer's disease.
    Bigl V; Schliebs R
    J Neural Transm Suppl; 1998; 54():237-47. PubMed ID: 9850932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
    Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch EC
    Exp Neurol; 1997 May; 145(1):245-52. PubMed ID: 9184126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presynaptic cholinergic dysfunction in patients with dementia.
    Sims NR; Bowen DM; Allen SJ; Smith CC; Neary D; Thomas DJ; Davison AN
    J Neurochem; 1983 Feb; 40(2):503-9. PubMed ID: 6822833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.
    Slotkin TA; Nemeroff CB; Bissette G; Seidler FJ
    J Clin Invest; 1994 Aug; 94(2):696-702. PubMed ID: 8040324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary hippocampal neuronal cell death induction after acute and repeated paraquat exposures mediated by AChE variants alteration and cholinergic and glutamatergic transmission disruption.
    Del Pino J; Moyano P; Díaz GG; Anadon MJ; Diaz MJ; García JM; Lobo M; Pelayo A; Sola E; Frejo MT
    Toxicology; 2017 Sep; 390():88-99. PubMed ID: 28916328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
    Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
    Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.
    Orta-Salazar E; Cuellar-Lemus CA; Díaz-Cintra S; Feria-Velasco AI
    Neurologia; 2014 Oct; 29(8):497-503. PubMed ID: 23433740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain mechanisms in Alzheimer's disease.
    Coyle JT; Price DL; DeLong MR
    Hosp Pract (Off Ed); 1982 Nov; 17(11):55-63. PubMed ID: 6127308
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
    Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
    Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease.
    Xuereb JH; Perry EK; Candy JM; Bonham JR; Perry RH; Marshall E
    J Neurol Sci; 1990 Nov; 99(2-3):185-97. PubMed ID: 1964958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
    Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
    Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.
    Boissière F; Faucheux B; Agid Y; Hirsch EC
    Neurosci Lett; 1997 Apr; 225(3):169-72. PubMed ID: 9147397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta-Amyloid excitotoxicity in rat magnocellular nucleus basalis. Effect of cortical deafferentation on cerebral blood flow regulation and implications for Alzheimer's disease.
    Harkany T; Penke B; Luiten PG
    Ann N Y Acad Sci; 2000 Apr; 903():374-86. PubMed ID: 10818528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
    Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
    Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
    Bowen DM; Allen SJ; Benton JS; Goodhardt MJ; Haan EA; Palmer AM; Sims NR; Smith CC; Spillane JA; Esiri MM; Neary D; Snowdon JS; Wilcock GK; Davison AN
    J Neurochem; 1983 Jul; 41(1):266-72. PubMed ID: 6306169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nucleus basalis in Huntington's disease.
    Clark AW; Parhad IM; Folstein SE; Whitehouse PJ; Hedreen JC; Price DL; Chase GA
    Neurology; 1983 Oct; 33(10):1262-7. PubMed ID: 6225032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.